The contraceptive devices market has seen considerable growth due to a variety of factors.
• The contraceptive devices market has expanded significantly in recent years. It is expected to rise from $12.8 billion in 2024 to $13.66 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.7%.
This growth can be attributed to increased awareness about family planning and contraceptive methods, government initiatives, the rising global population, a focus on women's health and empowerment, and improved access to healthcare facilities.
The contraceptive devices market is expected to maintain its strong growth trajectory in upcoming years.
• The contraceptive devices market is expected to grow to $17.47 billion by 2029, with a CAGR of 6.4%.
The growth will be supported by increasing sexual health awareness, economic benefits of controlling family size, greater cultural acceptance of contraceptive use, a large proportion of young individuals in reproductive age, and the influence of social media in spreading awareness. Key trends include advancements in contraceptive technologies, educational initiatives by NGOs, new pharmaceutical formulations, availability of diverse contraceptive options, and more investment in R&D for new methods.
The rising incidence of sexually transmitted diseases (STDs) is anticipated to drive the growth of the contraceptive device market. STDs, transmitted primarily through sexual contact, can cause various health issues. The increase in STDs is attributed to factors such as more sexual activity, inadequate protection, lack of sexual health education, and limited access to healthcare. Contraceptive devices, particularly condoms, are essential in preventing the spread of STDs by creating a barrier that limits exposure to infectious fluids and lesions. For instance, a 2024 report by the UK Health Security Agency indicated that in England, 401,800 new STI cases were diagnosed in 2023, marking a 4.7% increase from 2022. The rise in STD cases is thus fueling the demand for contraceptive devices.
The contraceptive devices market covered in this report is segmented –
1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types
2) By Technology: Hormonal Contraceptives, Barrier Contraceptives
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels
Subsegments:
1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills
2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices
3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms
4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges
5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings
6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs
7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants
8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams
Companies in the contraceptive device market are developing innovative products like contraceptive vaginal rings for convenient, low-maintenance birth control. These rings release hormones to prevent pregnancy and can be used for a month before being replaced. In October 2023, Xiromed launched EnilloRing, a contraceptive vaginal ring combining etonogestrel and ethinyl estradiol for long-term use and effective pregnancy prevention.
Major companies operating in the contraceptive devices market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Organon Group
• Hologic Inc.
• CooperSurgical Inc.
• Cipla Inc.
• Mankind Pharma Ltd.
• TTK HealthCare Ltd.
• Zondervan
• Merck Sharp & Dohme Corp.
• Evofem Biosciences Inc.
• Veru Inc.
• Medisafe Inc.
• Agile Therapeutics Inc.
• Janssen Global Services LLC
• HLL Lifecare Ltd.
• Mayer Laboratories Inc.
• V-Care Pharma Pvt. Ltd.
• Vardhaman Lifecare Pvt. Ltd.
• Actavis Pharma LLC
• Pregna International Limited
North America was the largest region in the contraceptive devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.